+Search query
-Structure paper
Title | Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 Antibody. |
---|---|
Journal, issue, pages | Mol. Cancer Ther., Vol. 19, Page 2105-2116, Year 2020 |
Publish date | Jun 27, 2020 (structure data deposition date) |
Authors | Al-Khami, A.A. / Youssef, S. / Abdiche, Y. / Nguyen, H. / Chou, J. / Kimberlin, C.R. / Chin, S.M. / Kamperschroer, C. / Jessen, B. / Kern, B. ...Al-Khami, A.A. / Youssef, S. / Abdiche, Y. / Nguyen, H. / Chou, J. / Kimberlin, C.R. / Chin, S.M. / Kamperschroer, C. / Jessen, B. / Kern, B. / Budimir, N. / Dillon, C.P. / Xu, A. / Clark, J.D. / Kraynov, E. / Rajpal, A. / Lin, J.C. / Salek-Ardakani, S. |
External links | Mol. Cancer Ther. / PubMed:32847983 |
Methods | X-ray diffraction |
Resolution | 2.59 Å |
Structure data | PDB-6xkr: |
Chemicals | ChemComp-GOL: ChemComp-HOH: |
Source |
|
Keywords | ANTITUMOR PROTEIN/IMMUNE SYSTEM / anti-PD-1 / Fab / Complex / Immuno-Oncology / ANTITUMOR PROTEIN / ANTITUMOR PROTEIN-IMMUNE SYSTEM complex |